Hopegest 200mg Tablet SR contains Progesterone, a naturally occurring steroid hormone essential for regulating the menstrual cycle and maintaining pregnancy. This sustained-release formulation ensures a gradual and consistent release of progesterone, providing prolonged therapeutic effects. It is primarily indicated for the treatment of progesterone deficiency, support of luteal phase in assisted reproductive technology (ART), prevention of endometrial hyperplasia in hormone replacement therapy (HRT), and management of amenorrhea or abnormal uterine bleeding due to hormonal imbalance. Hopegest 200mg Tablet SR is also utilized in the management of threatened miscarriage and to support early pregnancy in cases of infertility. The sustained-release mechanism enhances patient compliance by reducing dosing frequency and maintaining stable plasma progesterone levels. Administration should be as prescribed by a healthcare professional, typically orally once daily, preferably at the same time each day. Common side effects may include headache, breast tenderness, dizziness, and mild gastrointestinal disturbances. Contraindications include known hypersensitivity to progesterone or any component of the formulation, active thromboembolic disorders, liver dysfunction, and undiagnosed vaginal bleeding. Caution is advised in patients with a history of cardiovascular disease or hormone-sensitive malignancies. Regular monitoring and consultation with a healthcare provider are recommended to ensure safe and effective use.